Does CLOBAZAM Cause Salivary hypersecretion? 52 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 52 reports of Salivary hypersecretion have been filed in association with CLOBAZAM (Clobazam). This represents 0.5% of all adverse event reports for CLOBAZAM.
52
Reports of Salivary hypersecretion with CLOBAZAM
0.5%
of all CLOBAZAM reports
7
Deaths
32
Hospitalizations
How Dangerous Is Salivary hypersecretion From CLOBAZAM?
Of the 52 reports, 7 (13.5%) resulted in death, 32 (61.5%) required hospitalization, and 15 (28.8%) were considered life-threatening.
Is Salivary hypersecretion Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CLOBAZAM. However, 52 reports have been filed with the FAERS database.
What Other Side Effects Does CLOBAZAM Cause?
Drug ineffective (1,918)
Seizure (1,787)
Off label use (957)
Somnolence (890)
Foetal exposure during pregnancy (531)
Multiple-drug resistance (486)
Epilepsy (464)
Drug interaction (431)
Fatigue (418)
Status epilepticus (366)
What Other Drugs Cause Salivary hypersecretion?
CLOZAPINE (1,349)
ARIPIPRAZOLE (497)
RISPERIDONE (485)
OLANZAPINE (449)
QUETIAPINE (299)
CARBIDOPA\LEVODOPA (248)
HALOPERIDOL (216)
DIAZEPAM (185)
CLONAZEPAM (179)
LORAZEPAM (165)
Which CLOBAZAM Alternatives Have Lower Salivary hypersecretion Risk?
CLOBAZAM vs CLOBETASOL
CLOBAZAM vs CLOBETASONE
CLOBAZAM vs CLODRONATE
CLOBAZAM vs CLOFARABINE
CLOBAZAM vs CLOFAZIMINE